107 related articles for article (PubMed ID: 35150532)
41. Resection margins and local recurrences in breast cancer: Comparison between conventional and oncoplastic breast conserving surgery.
Niinikoski L; Leidenius MHK; Vaara P; Voynov A; Heikkilä P; Mattson J; Meretoja TJ
Eur J Surg Oncol; 2019 Jun; 45(6):976-982. PubMed ID: 30795953
[TBL] [Abstract][Full Text] [Related]
42. Surgical management of ipsilateral breast tumor recurrence.
Kolben T; Schwarz TM; Goess C; Blume C; Degenhardt T; Engel J; Wuerstlein R; Ditsch N; Harbeck N; Kahlert S
Int J Surg; 2015 Nov; 23(Pt A):141-6. PubMed ID: 26449651
[TBL] [Abstract][Full Text] [Related]
43. Is complete pathological response truly a complete response in breast cancer?
Rehman B; Rehman S; Mohtasham S; Zahid T; Sarwar A; Parvaiz MA
J Pak Med Assoc; 2023 Feb; 73(2):280-283. PubMed ID: 36800710
[TBL] [Abstract][Full Text] [Related]
44. [Treatment results following breast-conserving therapy in primary breast cancer].
Fehlauer F; Weinhold HD; Kolberg HC; Lindenkamp M; Schulte R; Mahlmann B; Richter E; Feyerabend T
Zentralbl Gynakol; 2005 Feb; 127(1):31-6. PubMed ID: 15702448
[TBL] [Abstract][Full Text] [Related]
45. Negative margin status improves local control in conservatively managed breast cancer patients.
Obedian E; Haffty BG
Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
[TBL] [Abstract][Full Text] [Related]
46. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol.
Blichert-Toft M; Nielsen M; Düring M; Møller S; Rank F; Overgaard M; Mouridsen HT
Acta Oncol; 2008; 47(4):672-81. PubMed ID: 18465335
[TBL] [Abstract][Full Text] [Related]
47. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
48. Factors affecting locoregional recurrence in breast cancer patients undergoing surgery following neoadjuvant treatment.
Chou HH; Chung WS; Ding RY; Kuo WL; Yu CC; Tsai HP; Shen SC; Chu CH; Lo YF; Chen SC
BMC Surg; 2021 Mar; 21(1):160. PubMed ID: 33757489
[TBL] [Abstract][Full Text] [Related]
49. Repeat lumpectomy for patients with ipsilateral breast tumor recurrence after breast-conserving surgery. Preliminary results.
Komoike Y; Motomura K; Inaji H; Kasugai T; Koyama H
Oncology; 2003; 64(1):1-6. PubMed ID: 12457024
[TBL] [Abstract][Full Text] [Related]
50. Local recurrence risk after previous salvage mastectomy.
Tanabe M; Iwase T; Okumura Y; Yoshida A; Masuda N; Nakatsukasa K; Shien T; Tanaka S; Komoike Y; Taguchi T; Arima N; Nishimura R; Inaji H; Ishitobi M;
Eur J Surg Oncol; 2016 Jul; 42(7):980-5. PubMed ID: 27055945
[TBL] [Abstract][Full Text] [Related]
51. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
Mechera R; Viehl CT; Oertli D
Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
[TBL] [Abstract][Full Text] [Related]
52. Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients.
Shin HC; Han W; Moon HG; Im SA; Moon WK; Park IA; Park SJ; Noh DY
Ann Surg Oncol; 2013 Aug; 20(8):2582-9. PubMed ID: 23504119
[TBL] [Abstract][Full Text] [Related]
53. Predicting loco-regional recurrence risk in T1, T2 breast cancer with 1-3 positive axillary nodes postmastectomy: Development of a predictive nomogram.
Wadasadawala T; Kannan S; Gudi S; Rishi A; Budrukkar A; Parmar V; Shet T; Desai S; Gupta S; Badwe R; Sarin R
Indian J Cancer; 2017; 54(1):352-357. PubMed ID: 29199721
[TBL] [Abstract][Full Text] [Related]
54. How safe is oncoplastic breast conservation? Comparative analysis with standard breast conserving surgery.
Chakravorty A; Shrestha AK; Sanmugalingam N; Rapisarda F; Roche N; Querci Della Rovere G; Macneill FA
Eur J Surg Oncol; 2012 May; 38(5):395-8. PubMed ID: 22436560
[TBL] [Abstract][Full Text] [Related]
55. Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
Wang J; Wang S; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Ren H; Yu Z; Li Y
Clin Breast Cancer; 2018 Oct; 18(5):e975-e984. PubMed ID: 30054238
[TBL] [Abstract][Full Text] [Related]
56. [Breast cancer: locoregional recurrence and subsequent disease course].
Benz J; Juchler A
Helv Chir Acta; 1992 May; 59(1):273-8. PubMed ID: 1526842
[TBL] [Abstract][Full Text] [Related]
57. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
[TBL] [Abstract][Full Text] [Related]
58. Breast conserving surgery in combination with intraoperative radiotherapy after previous external beam therapy: an option to avoid mastectomy.
Thangarajah F; Heilmann J; Malter W; Kunze S; Marnitz S; Mallmann P; Wenz F; Sperk E
Breast Cancer Res Treat; 2018 Apr; 168(3):739-744. PubMed ID: 29335922
[TBL] [Abstract][Full Text] [Related]
59. Long-Term Survival Differences Between T1-2 Invasive Lobular Breast Cancer and Corresponding Ductal Carcinoma After Breast-Conserving Surgery: A Propensity-Scored Matched Longitudinal Cohort Study.
Wang K; Zhu GQ; Shi Y; Li ZY; Zhang X; Li HY
Clin Breast Cancer; 2019 Feb; 19(1):e101-e115. PubMed ID: 30502219
[TBL] [Abstract][Full Text] [Related]
60. Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial.
Arthur DW; Winter KA; Kuerer HM; Haffty B; Cuttino L; Todor DA; Anne PR; Anderson P; Woodward WA; McCormick B; Cheston S; Sahijdak WM; Canaday D; Brown DR; Currey A; Fisher CM; Jagsi R; Moughan J; White JR
JAMA Oncol; 2020 Jan; 6(1):75-82. PubMed ID: 31750868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
